Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach

• Auteurs principaux: Paolo Immovilli (Auteur), Nicola Morelli (Auteur), Chiara Terracciano (Auteur), Eugenia Rota (Auteur), Elena Marchesi (Auteur), Stefano Vollaro (Auteur), Paola De Mitri (Auteur), Domenica Zaino (Auteur), Veronica Bazzurri (Auteur), Donata Guidetti (Auteur)
• Format: Livre
• Publié: MDPI AG, 2022-04-01T00:00:00Z.
• Sujets: article
• Accès en ligne: Connect to this object online.

The COVID-19 pandemic poses an ongoing global challenge, and several risk factors make people with multiple sclerosis (pwMS) particularly susceptible to running a severe disease course. Although the literature does report numerous articles on the risk factors for severe COVID-19 and vaccination resp...